Skip to Content

Dear reader,

Last week I was reading about the “Electronic  Presciption” in Primary Care in Spain. Here, we have 17 Regional Governments, and each one has developed their own solution.

In a blog of one of these regions, someone talked about the big amount of money that  this kind of solutions save. That’s true, and I can’t add anything. In Spain, we have other studies that demonstrate this:Our customers have a quick Return of Investment (ROI) when they implement our Healthcare Solutions. You can find some figures above: you will see some figures of Hospital Clínic de Barcelona (ROI Study done by IDC in 2007), and some details about  the implementation of SAP for Healthcare in Institut Català de la Salut (Public group with 8 hospitals).

 

 

 

 

 

(Click here to see the document)

I agree: financial ROI is very important, and with the current economic environment, perhaps it’s more important. Organizations need to know the ROI to invest in Software and Technology.

We are proud of these studies; they reflect that our customers are saving costs with our healthcare solutions.

But, reading a lot of figures, I thought about some other benefits of Electronic Prescription: easy way to identify drug incompatibility problems, allergies, “current medication” of the patient accessible from any point of the healthcare network, etc.

I know that all of you know these advantages, but, reading that blog, I had the feeling that sometimes we only look through the economic window. And it’s very difficult to price the fact of detecting an incompatibility between drugs.

So, let me summarize: I agree with the idea that the financial ROI is very important, but there is other ROI, perhaps we could name it “Quality ROI”, where the KPIs are not in terms of money, they are in terms of Quality, Safety, Satisfaction, etc..

To report this post you need to login first.

2 Comments

You must be Logged on to comment or reply to a post.

  1. Bill Wood
    Interesting take.  However, the drug interaction has both tangible and intangible financial impacts.  Reducing the # of drug interactions per 1000 patients could result in lower legal fees or other costs associated with that.  It could reduce the physical cost of follow-on treatment, and it also has the possibility of avoiding damaging your reputation.

    Quantifiable cost avoidance is a valid ROI measure, just as valid as cost-reduction.

    I’ve written a LOT on the subject of ROI and what it takes to achieve that in SAP projects.

    You can see a lot of the material on my site, http://www.r3now.com

    Or right here there are a couple of articles as well:

    Why SAP Projects Fail to Deliver ROI (and how to change it)

    Why SAP Projects Fail to Deliver ROI (and how to change it)

    http://www.r3now.com/modules.php?name=news&file=article&sid=17

    (0) 
    1. Jose Maria Bornas Post author
      Hi Bill,
      First of all, thank you very much for your feedback. I agree with your comment, and I will read your articles, I’m very interested in this topic.
      I agree with your point of view. Sure that, for example, drug interaction has financial impacts.
      What I was trying to explain is that, from my point of view, sometimes we forget these intangible financial impact. Things that are very important for the patient, and for a quality care.
      So, I think we share the same idea.
      (0) 

Leave a Reply